{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Investigational
Source:
INN:eltivutabart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03500380: Phase 2/Phase 3 Interventional Active, not recruiting Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02129075: Phase 2 Interventional Completed Cutaneous Melanoma
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03526835: Phase 1/Phase 2 Interventional Recruiting Advanced/Metastatic Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ozuriftamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:volrustomig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nivisnebart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sovipostobart beta [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ivonescimab [INN]
Source URL:
Class:
PROTEIN
